Canris Pharma India Private Limited
About Canris Pharma India Private Limited
Data last updated:
Canris Pharma India Private Limited was a private limited company based in Bangalore, Karnataka, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 March 2012.
The company was registered with the Registrar of Companies (ROC), Bangalore, under CIN U85100KA2012PTC063264. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Chikkapura Shanthaveerappa Nagaraja and Mohan Kumar Rajanna.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at 304 3rd Floor Sri Lakshmi Residency Katriguppe Main Road Bsk 3rd Stage, Bangalore, Karnataka, India – 560085.
Company details
Contact details
Canris Pharma India Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address304 3rd Floor Sri Lakshmi Residency Katriguppe Main Road Bsk 3rd Stage, Bangalore, Karnataka, India – 560085
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Canris Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Canris Pharma India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Canris Pharma India Private Limited, buy the company report.
Financials of Canris Pharma India Private Limited
FY 2020 filings availableCanris Pharma India Private Limited reported revenue of ₹7,573 (down 98% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 66% over five years, including a 98% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Canris Pharma India Private Limited, buy the company report.
Board of directors of Canris Pharma India Private Limited
Canris Pharma India has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chikkapura Shanthaveerappa Nagaraja | Director | 28 Mar 2012 | 14 Years 6 Months | As last reported |
| Mohan Kumar Rajanna | Director | 05 Dec 2016 | 9 Years 10 Months | As last reported |
| Mahantesh Rachayya Charantimath | Director | 05 Dec 2016 | 9 Years 10 Months | As last reported |
| Devarahally Karibasavashastry Jamuna | Director | 28 Mar 2012 | 14 Years 6 Months | As last reported |
Auditor
Canris Pharma India Private Limited is audited by SHIVAPRAKASH J & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHIVAPRAKASH J & CO | FY 2017 | 015100S |
Shareholding
The shareholding of Canris Pharma India Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Canris Pharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Canris Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Canris Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Canris Pharma India has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Canris Pharma India Private Limited, buy the company report.
Recent activity
Canris Pharma India Private Limited has 6 board changes on record since 2012: 4 appointments and 2 cessations. The latest: Venkatesh Prasanna Kumar ceased to be Director on 02 Aug 2018.
Frequently asked questions
Canris Pharma India has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Canris Pharma India was a private limited company based in Bangalore, Karnataka, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 March 2012 and is registered under CIN U85100KA2012PTC063264. The company has been struck off by the Registrar of Companies and is no longer operational.
Canris Pharma India had 4 directors:
- Chikkapura Shanthaveerappa Nagaraja - Director
- Mohan Kumar Rajanna - Director
- Mahantesh Rachayya Charantimath - Director
- Devarahally Karibasavashastry Jamuna - Director
The CIN (Corporate Identification Number) of Canris Pharma India is U85100KA2012PTC063264. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Canris Pharma India is at 304 3rd Floor Sri Lakshmi Residency Katriguppe Main Road Bsk 3rd Stage, Bangalore, Karnataka, India – 560085.
Canris Pharma India was incorporated on 28 March 2012. It is registered with the Registrar of Companies, Bangalore.
The latest financial statements of Canris Pharma India on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
No. Canris Pharma India has 1 GST registration on record and it is cancelled or inactive.
Canris Pharma India operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.
Venkatesh Prasanna Kumar ceased to be Director on 02 Aug 2018. Devarahally Karibasavashastry Jamuna ceased to be Director on 05 Dec 2016. Mahantesh Rachayya Charantimath was appointed as Director on 05 Dec 2016. Canris Pharma India has 6 board changes on record in total.